Pulmonary Outcomes on Patients With Lung Fibrosis

N/AActive Not RecruitingNCT07088185

South Valley University60 enrolled

Overview

The pulmonary fibrosis is lung disease that occurs when lung tissue become damaged and scarred. The objectives of treatment are to improve symptoms and quality of life, and slow disease progression.

This study will include 60 patients with pulmonary fibrosis from both gender who are aged from 35 - 55 years old.This study will be randomized controlled trial.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

NONE

Enrollment

Conditions

Lung Fibrosis

Interventions

Routine medical careOTHER

Routine medical care

Pulmonary rehabilitationOTHER

Pulmonary rehabilitation ( breathing exercises, posture drainage, additive techniques with postural drainage like vibration,shaking and percussion, active cycle of breathing techniques, autogenic drainage) plus routine care.

Eligibility

Sex: ALLMin age: 35 YearsMax age: 55 Years

Medical Language ↔ Plain English

Inclusion Criteria: * both gender. * patients with cystic fibrosis. Exclusion Criteria: * severe chronic disorders. * heart failure * respiratory failure. * age less than 35 or older than 55 years old.

Locations (1)

South valley university

Qina, Egypt

Outcomes

Primary Outcomes

FVC

Forced vital capacity (FVC).

Time frame: One month

FEV1

Forced expiratory volume in the first second (FEV1)

Time frame: One month

The FEV1 on FVC

The ratio between FEV1 and FVC

Time frame: One month.

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.